Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 62Active not recruiting 50Not yet recruiting 14Completed 13Terminated 12Withdrawn 7Suspended 4Enrolling by invitation 3Unknown 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Other hematologic neoplasm 1

Conditions

Stomach Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Oxaliplatin 283Capecitabine 217Fluorouracil 210Irinotecan 145Leucovorin 136Gemcitabine 121S 1 (combination) 110apatinib 108Cisplatin 99Radiotherapy 97Bevacizumab 97Drug Therapy 94Paclitaxel 93camrelizumab 88sintilimab 77Cetuximab 74lenvatinib 60Neoadjuvant Therapy 59tislelizumab 54Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 52Docetaxel 51toripalimab 50130-nm albumin-bound paclitaxel 45Laparoscopy 41HMPL-013 40XELOX 38Albumin-Bound Paclitaxel 36regorafenib 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Specimen Handling × Gastrointestinal × Clear all
NCT04535401 2024-10-10

Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines

National Cancer Institute (NCI)

Phase 1 Unknown
10 enrolled
Gastrointestinal

Stomach Neoplasms, Colorectal Neoplasms

NCT06017141 2023-08-30

Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study

University of Kansas Medical Center

Phase 2 Unknown
80 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡